What is Saebo?
Saebo specializes in developing and distributing award-winning therapeutic products aimed at enhancing mobility and neurological function for individuals recovering from strokes. Their comprehensive product line addresses rehabilitation needs for the hand, arm, shoulder, and foot, alongside solutions for pain management. The company serves a diverse clientele, including stroke survivors, rehabilitation clinicians, and veterans seeking specialized pain relief, positioning itself as a key player in the restorative healthcare sector. Saebo's commitment to maximizing recovery potential is supported by effective rehabilitation resources and educational initiatives.
How much funding has Saebo raised?
Saebo has raised a total of $458K across 2 funding rounds:
Debt
$150K
Debt
$308K
Debt (2020): $150K with participation from PPP
Debt (2021): $308K led by PPP
What's next for Saebo?
With its recent large-scale late-stage funding, Saebo is strategically positioned for accelerated growth and product development. The infusion of capital is expected to fuel further innovation in their stroke rehabilitation technologies and expand their market reach, potentially exploring new therapeutic applications or enhancing existing product lines. This strategic investment will likely enable Saebo to scale its operations, strengthen its distribution channels, and further solidify its leadership in the competitive rehabilitation therapy market, ultimately aiming to improve the quality of life for a greater number of patients.
See full Saebo company page
